Duloxetin for oxaliplatin-induced peripheral neuropathy in colorectal cancer patients with depression.
Phase 2
- Conditions
- Colorectal cancer
- Registration Number
- JPRN-UMIN000013969
- Lead Sponsor
- Kobe City Medical Center General Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
Not provided
Exclusion Criteria
1) pregnant or female intend to be pregnant, and male intend to make pregnant. 2) uncontrollable serious mental problem 3) peripheral neuropathy with other drug 4) uncontrolled diabetes mellitus 5) patients who receives antineuropathy therapy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method prolongation of period of oxaliplatin treatment
- Secondary Outcome Measures
Name Time Method evaluation of peripheral neuropath, QOL, safety, total dose of oxaliplatin